CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-23 | ORBIMED ADVISORS LLC Director | Sale | −69,500 | $13.03 | $906K | 83,695 |
| 2024-08-22 | Thompson Peter A. Director | Sale | −391,482 | $12.94 | $5.1M | 153,195 |
| 2024-08-22 | ORBIMED ADVISORS LLC Director | Sale | −391,482 | $12.94 | $5.1M | 153,195 |
| 2024-08-21 | Thompson Peter A. Director | Sale | −394,400 | $13.52 | $5.3M | 557,977 |
| 2024-08-21 | Thompson Peter A. Director | Sale | −13,300 | $14.61 | $194K | 544,677 |
| 2024-08-21 | ORBIMED ADVISORS LLC Director | Sale | −394,400 | $13.52 | $5.3M | 557,977 |
| 2024-08-21 | ORBIMED ADVISORS LLC Director | Sale | −13,300 | $14.61 | $194K | 544,677 |
| 2024-08-20 | Dorsey Brian Chief Operating Officer | Option exercise 10b5-1 | +50,000 | $0.64 | $32K | 56,024 |
| 2024-08-20 | Dorsey Brian Chief Operating Officer | Sale 10b5-1 | −50,000 | $15.00 | $750K | 6,024 |
| 2024-08-20 | Dorsey Brian Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 61,828 | ||
| 2024-08-20 | Scott Kathleen D. Chief Financial Officer | Option exercise 10b5-1 | +12,500 | $1.50 | $19K | 25,699 |
| 2024-08-20 | Scott Kathleen D. Chief Financial Officer | Sale 10b5-1 | −12,500 | $16.00 | $200K | 13,199 |
| 2024-08-20 | Scott Kathleen D. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 814,830 | ||
| 2024-08-20 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −35,944 | $14.76 | $530K | 1,511,503 |
| 2024-08-20 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −11,756 | $15.61 | $184K | 1,499,747 |
| 2024-08-20 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,300 | $16.26 | $37K | 1,497,447 |
| 2024-08-20 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −36,216 | $14.76 | $534K | 1,512,283 |
| 2024-08-20 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −11,523 | $15.62 | $180K | 1,500,760 |
| 2024-08-20 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,261 | $16.25 | $37K | 1,498,499 |
| 2024-08-20 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −35,944 | $14.76 | $530K | 1,511,503 |
Page 12 of 14 · 267 trades